In accordance with Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed newspaper publication of Standalone Audited Financial ....
Awaiting price reaction for this filing.
Dharti Proteins Ltd has submitted a regulatory filing under SEBI LODR Regulations 30 and 47, confirming publication of its standalone audited financial results for Q4 and FY ended March 31, 2026. The results were published in Financial Express (English and Gujarati editions) on May 30, 2026. The filing includes a newspaper clipping as supporting attachment. The company's BSE script code is 531171 (DHARTI) and ISIN is INE248C01013. The filing is digitally signed by Twinkle Bipinchandra Gajjar, Company Secretary and Compliance Officer.
This is a routine compliance filing. The financial numbers from the newspaper clipping are not fully legible in the document, so investors should refer to the full financial results filed separately under Regulation 33 or available on BSE/NSE websites for detailed performance figures.